Protection of LPS-Induced Murine Acute Lung Injury by Sphingosine-1-Phosphate Lyase Suppression
Yutong Zhao,Irina Gorshkova,Evgeny V. Berdyshev,Donghong He,Panfeng Fu,Wenli Ma,Yanlin Su,Peter V. Usatyuk,Srikanth Pendyala,Babak Oskouian,Julie D. Saba,Joe G.N. Garcia,Viswanathan Natarajan +12 more
Reads0
Chats0
TLDR
A novel role for intracellularly generated S1P in protection against ALI is identified and S1PL is suggested as a potential therapeutic target.Abstract:
A defining feature of acute lung injury (ALI) is the increased lung vascular permeability and alveolar flooding, which leads to associated morbidity and mortality. Specific therapies to alleviate the unremitting vascular leak in ALI are not currently clinically available; however, our prior studies indicate a protective role for sphingosine-1-phosphate (S1P) in animal models of ALI with reductions in lung edema. As S1P levels are tightly regulated by synthesis and degradation, we tested the hypothesis that inhibition of S1P lyase (S1PL), the enzyme that irreversibly degrades S1P via cleavage, could ameliorate ALI. Intratracheal instillation of LPS to mice enhanced S1PL expression, decreased S1P levels in lung tissue, and induced lung inflammation and injury. LPS challenge of wild-type mice receiving 2-acetyl-4(5)-[1(R),2(S),3(R),4-tetrahydroxybutyl]-imidazole to inhibit S1PL or S1PL+/− mice resulted in increased S1P levels in lung tissue and bronchoalveolar lavage fluids and reduced lung injury and inflam...read more
Citations
More filters
Journal ArticleDOI
Sphingosine-1-phosphate signaling and its role in disease
TL;DR: The bioactive sphingolipid metabolite sphingosine-1-phosphate (S1P) is now recognized as a critical regulator of many physiological and pathophysiological processes, including cancer, atherosclerosis, diabetes and osteoporosis.
Journal ArticleDOI
Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease.
Joseph W. Golden,Curtis R. Cline,Xiankun Zeng,Aura R. Garrison,Brian D. Carey,Eric M. Mucker,Lauren E. White,Joshua D. Shamblin,Rebecca L. Brocato,Jun Liu,April M. Babka,Hypaitia B. Rauch,Jeffrey M. Smith,Bradley S. Hollidge,Collin Fitzpatrick,Catherine V. Badger,Jay W. Hooper +16 more
TL;DR: To the authors' knowledge, this is the first highly lethal murine infection model for SARS-CoV-2 and should be valuable for the study of Sars-Cov-2 pathogenesis and for the assessment of MCMs.
Journal ArticleDOI
Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury
Viswanathan Natarajan,Steven M. Dudek,Jeffrey R. Jacobson,Liliana Moreno-Vinasco,Long Shuang Huang,Taimur Abassi,Biji Mathew,Yutong Zhao,Lichun Wang,Robert Bittman,Ralph R. Weichselbaum,Evgeny V. Berdyshev,Joe G.N. Garcia +12 more
TL;DR: S1P is a potent angiogenic factor that enhances lung endothelial cell integrity and an inhibitor of vascular permeability and alveolar flooding in preclinical animal models of ALI, and S1P analogues such as 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol (FTY720) phosphate, and FTY720 phosphonates offer therapeutic potential in murine models of lung injury.
Journal ArticleDOI
Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1
Sabine Vettorazzi,Sabine Vettorazzi,Constantin Bode,Lien Dejager,Lucien Frappart,Ekaterina Shelest,Carina Klaßen,Alpaslan Tasdogan,Holger M. Reichardt,Claude Libert,Marion Schneider,Falk Weih,N. Henriette Uhlenhaut,Jean-Pierre David,Markus H. Gräler,Anna Kleiman,Jan Tuckermann,Jan Tuckermann +17 more
TL;DR: Findings support a critical role for SphK1 induction in the suppression of lung inflammation by glucocorticoids, and therefore provide rationales for effective anti-inflammatory therapies.
Book ChapterDOI
S1P Control of Endothelial Integrity
Yuquan Xiong,Timothy Hla +1 more
TL;DR: The recent discovery of the endothelium-protective functions of HDL-bound S1P which is chaperoned by apolipoprotein M is discussed, which is important for the modulation of vascular permeability.
References
More filters
Journal ArticleDOI
Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate
Rajita Pappu,Susan R. Schwab,Ivo Cornelissen,João Pereira,Jean B. Regard,Ying Xu,Eric Camerer,Yaowu Zheng,Yong Huang,Jason G. Cyster,Shaun R. Coughlin +10 more
TL;DR: Separate sources provide S1P to plasma and lymph to help lymphocytes exit the low-S1P environment of lymphoid organs, and disruption of compartmentalized S 1P signaling is a plausible mechanism by which S1p-receptor-1 agonists function as immunosuppressives.
Journal ArticleDOI
Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement
Joe G.N. Garcia,Feng Liu,Alexander D. Verin,Anna A. Birukova,Melissa A. Dechert,William T. Gerthoffer,James R. Bamberg,Denis English +7 more
TL;DR: Platelet-released sphingosine 1-phosphate, linked to Rac- and Rho-dependent cytoskeletal rearrangement, may act late in angiogenesis to stabilize newly formed vessels, which often display abnormally increased vascular permeability.
Journal ArticleDOI
Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients
TL;DR: It is concluded that lymphocyte egress is mediated by S 1P gradients that are established by S1P lyase activity and that the lyase may represent a novel immunosuppressant drug target.
Journal ArticleDOI
Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network
Hugh Rosen,Edward J. Goetzl +1 more
TL;DR: Recent results that indicate that S1P and its receptors are required for the emigration of thymocytes from the thymus, the trafficking of lymphocytes in secondary lymphoid organs and the migration of B cells into splenic follicles are discussed.
Journal ArticleDOI
Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury.
Xinqi Peng,Paul M. Hassoun,Saad Sammani,Bryan J. McVerry,Melissa J. Burne,Hamid Rabb,David B. Pearse,Rubin M. Tuder,Joe G.N. Garcia +8 more
TL;DR: It is indicated that S1P significantly decreases pulmonary/renal vascular leakage and inflammation in a murine model of LPS-mediated acute lung injury and may represent a novel therapeutic strategy for vascular barrier dysfunction.